Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

An interview with Franco Negron
In this interview, we spoke with Franco Negron, CEO of Simtra, about how the company is advancing its position as a premier CDMO for sterile injectables while preparing for the next wave of complex biologics. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Symeres Expands Spray Drying Capabilities to Accelerate Complex Small Molecule Development
Wednesday, June 10, 2026
Symeres has expanded its spray drying capabilities at its Cranbury, New Jersey, Chemistry, Manufacturing and Controls (CMC) development site to ... read more
Axplora Consolidates UDCA Manufacturing at Vizag
Wednesday, June 10, 2026
Axplora announced the strategic consolidation of ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the PharmaZell business ... read more
Matica Biotechnology Engaged by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
Wednesday, June 10, 2026
Matica Biotechnology announce its engagement with University Health Network (UHN). The agreement includes cGMP manufacturing of an interleukin-10 (IL-... read more
Cytovance Biologics Launches In-House Cell Line Development with High-Yield Titers up to 10g/L
Wednesday, June 10, 2026
Cytovance Biologics announced the expansion of its mammalian cell culture capabilities with the addition of cell line development services, ... read more
Gaelic, Athlone Complete First Phase of Post-Merger Integration
Tuesday, June 09, 2026
Gaelic Laboratories and Athlone Laboratories have completed the first phase of their post-merger integration, aligning key systems and capabilities ... read more